SHAREHOLDER ALERT: WeissLaw LLP Reminds DMYD, EIDX, IPHI, and MCAC Shareholders About Its Ongoing Investigations
Provided By PR Newswire
Last update: Dec 19, 2020
NEW YORK, Dec. 18, 2020 /PRNewswire/ --
If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
dMY Technology Group, Inc. II (NYSE: DMYD)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of dMY Technology Group, Inc. II (NYSE: DMYD) in connection with the company's proposed merger with Genius Sports Group Limited ("GSG"). Under the terms of the agreement, DMYD will acquire GSG through a reverse merger that will result in GSG becoming a public company. If you own DMYD shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/dmyd/
Eidos Therapeutics, Inc. (NASDAQ: EIDX)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Eidos Therapeutics, Inc. (NASDAQ: EIDX) in connection with the proposed interested-party acquisition of the company by BridgeBio Pharma, Inc. ("BridgeBio"). Under the terms of the agreement, EIDX shareholders can elect to receive either 1.85 shares of BridgeBio or $73.26 for each share of EIDX common stock that they own, subject to proration such that the aggregate cash portion will not exceed $175 million. Notably, an active alternative bidder offering nearly $50.00/share more is currently being frozen out and prevented from engaging with EIDX. If you own EIDX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/eidx/
Inphi Corporation (NASDAQ: IPHI)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Inphi Corporation (NASDAQ: IPHI) in connection with the company's proposed merger with Marvell Technology Group Ltd. ("MRVL"). Under the terms of the agreement, IPHI shareholders will receive $66.00 in cash and 2.323 shares of the newly-combined company for each IPHI share that they own. If you own IPHI shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/iphi/
Mountain Crest Acquisition Corp. (NASDAQ: MCAC)
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Mountain Crest Acquisition Corp. (NASDAQ: MCAC) in connection with the company's proposed merger with privately-held Playboy Enterprises, Inc. ("Playboy"). Under the terms of the agreement, MCAC will acquire Playboy through a reverse merger that will result in Playboy becoming a publicly-traded company. If you own MCAC shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/news/mcac/
View original content to download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-dmyd-eidx-iphi-and-mcac-shareholders-about-its-ongoing-investigations-301196312.html
SOURCE WeissLaw LLP
